T3	Treatment 18 29	hydroxyurea
T4	Subject 33 49	patients with ET
T6	Effect 62 95	therapy-associated acute leukemia
T8	Drug 18 29	hydroxyurea
T9	Treat-Disorder 47 49	ET
T10	Speculation_cue 50 53	may
T11	Freq 0 14	Prolonged used
T7	Adverse_event 70 80	associated
E1	Adverse_event:T7